This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
A novel treatment regimen for poor-prognosis or relapsed germ-cell tumors. Nat Rev Clin Oncol 4, 620–621 (2007). https://doi.org/10.1038/ncponc0947
Issue Date:
DOI: https://doi.org/10.1038/ncponc0947